Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) (2025)
Source: Atherosclerosis. Unidade: FM
Subjects: HEPATOPATIAS, FATORES DE RISCO, METABOLISMO DE GORDURA
ABNT
ITURBE-REY, Santiago et al. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis, v. 400, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/81950. Acesso em: 19 jun. 2025.APA
Iturbe-Rey, S., Maccali, C., Arrese, M., Aspichueta, P., Oliveira, C. P. M. S. de, Castro, R. E., et al. (2025). Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis, 400. doi:10.1016/j.atherosclerosis.2024.119053NLM
Iturbe-Rey S, Maccali C, Arrese M, Aspichueta P, Oliveira CPMS de, Castro RE, Lapitz A, Izquierdo-Sanchez L, Bujanda L, Perugorria MJ. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) [Internet]. Atherosclerosis. 2025 ; 400[citado 2025 jun. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/81950Vancouver
Iturbe-Rey S, Maccali C, Arrese M, Aspichueta P, Oliveira CPMS de, Castro RE, Lapitz A, Izquierdo-Sanchez L, Bujanda L, Perugorria MJ. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD) [Internet]. Atherosclerosis. 2025 ; 400[citado 2025 jun. 19 ] Available from: https://observatorio.fm.usp.br/handle/OPI/81950